Mirae Asset Global Etfs Holdings Ltd. Aura Biosciences, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 25,428 shares of AURA stock, worth $208,509. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,428
Previous 17,897
42.08%
Holding current value
$208,509
Previous $135,000
67.41%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AURA
# of Institutions
85Shares Held
37.6MCall Options Held
122KPut Options Held
38.5K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$56.8 Million2.94% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$47.6 Million0.91% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$40 Million0.08% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$24.9 Million5.63% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$24.6 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $240M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...